PRP for Tennis Elbow: A Regenerative Alternative When Cortisone and Rest Are Not Working

Tennis elbow is one of those conditions that sounds simple on paper and is anything but in real life. Patients describe months of nagging outer-elbow pain, weakness with gripping, and frustration with treatments that were supposed to work but did not. Rest helps a little, then the pain returns. Cortisone gives short-term relief, then the symptoms come back. For patients in this situation, PRP often enters the conversation as a regenerative alternative. This guide explains what tennis elbow actually is, why cortisone is often a limited tool for it, how PRP differs, and what to expect if your physician considers PRP for your case.

Tennis elbow, clinically known as lateral epicondylitis, is a tendon condition affecting the extensor tendons on the outer side of the elbow. Despite the name, most people who develop it do not play tennis. It is associated with repetitive gripping, lifting, and wrist motions in a wide variety of work and recreational activities.

The condition is fundamentally a tendinopathy. The tendon has not just temporarily inflamed; it has undergone structural changes that explain why simple rest often does not fully resolve symptoms. That difference matters when choosing a treatment.

At Tyrance Orthopedics & Sports Medicine, we approach tennis elbow through our pain management and our regenerative medicine, depending on what the case needs.

Cortisone reduces inflammation and can produce short-term relief for tennis elbow. The challenge is that tennis elbow is not primarily an inflammatory condition once it has settled into the chronic phase. Reducing inflammation does not address the underlying tendon issue.

The pattern that patients describe with cortisone for tennis elbow is often the same: relief for several weeks, then return of symptoms. Repeated cortisone injections in the same area over time are generally discouraged because of concerns about tissue effects with frequent use.

Cortisone is not useless for tennis elbow, but treating chronic tennis elbow with repeat cortisone is not a long-term strategy. That is why other options exist.

PRP is an autologous biologic. It uses platelets concentrated from your own blood, and the growth factors in the concentrate may support the body’s response in the targeted tendon area. For tennis elbow that has not responded to rest, physical therapy, and possibly cortisone, PRP is one of the regenerative options orthopedic surgeons consider.

PRP does not act like cortisone. There is no fast anti-inflammatory hit. The biologic response builds over weeks, and the goal is different: support tendon biology rather than suppress an inflammatory signal.

Realistic framing matters here. PRP is not guaranteed to fix every case of tennis elbow, and the way different practices prepare PRP varies. We discuss our specific approach during consultation and have written about realistic PRP expectations in our myths post.

A PRP appointment for tennis elbow at our Delray Beach office takes about 60 to 90 minutes. A small blood draw is processed in a centrifuge in the procedure room. The concentrate is injected into the affected tendon area under image guidance.

Mild soreness at the injection site for several days is common. Specific activity guidance for the first week and beyond is provided. PRP works through a gradual response, so improvements typically build over weeks rather than acting immediately.

Most patients drive themselves home afterward. We provide post-procedure instructions and answer follow-up questions between visits as the response unfolds.

PRP works best when it sits inside a broader plan that includes activity modification, targeted physical therapy, and addressing the activities that originally produced the tendon problem. PRP without a rehabilitation plan tends to underperform PRP with one.

For some patients PRP is the right step before considering surgical options. For others, PRP combined with a structured rehab plan is the durable answer without further intervention. The choice depends on the case and the response.

PRP is not FDA-approved for a specific medical condition. In Florida, PRP is offered legally with required disclosures so patients can make a fully informed decision during consultation. Results vary from patient to patient and are not guaranteed.

They are different tools. Cortisone provides faster short-term relief in some cases, but the relief often does not last and repeated cortisone is generally not the long-term answer. PRP works more gradually and aims at the tendon biology rather than the inflammatory symptom. The right choice depends on your case.

PRP works through a biologic response that builds over weeks. Many patients begin to notice changes over the first several weeks, with continued progression for several months. Some respond strongly, others modestly, and some do not respond meaningfully.

Activity is modified, not eliminated for most patients. Specific guidance depends on what the elbow is being asked to do and how the response is tracking. We will give you a clear picture of what activity is appropriate.

It depends on the case and the response to the first session. Some patients do well with a single injection. Others benefit from a short series. We discuss the realistic plan after evaluation.

Most insurance plans currently consider PRP investigational and do not cover it. Coverage varies by carrier and policy. We discuss the financial side individually during your consultation.

PRP is not guaranteed for any specific case. If response is incomplete or absent, the next conversation includes other regenerative options, additional rehabilitation strategies, or in select cases a surgical conversation. The path forward is honest based on what the elbow is showing.